Medscape

New Biologic Offers Hope for Hard-to-Treat COPD Patients

NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...
The National Institute for Health and Care Excellence

New hope for people with breathing condition, COPD, as NICE approves innovative treatment

Dupilumab, a simple pre-filled pen that people inject themselves with every two weeks, is the first biologic that targets both the symptoms of COPD and an underlying cause of the disease. It brings ...
PharmiWeb

NICE issued final draft guidance recommending dupilumab for eligible COPD patients, positioning it to become the first NHS-recommended biologic for COPD tr…

The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...
PharmiWeb

Revolutionary COPD diagnosis approach rolled out in UK first

UK: 11 November 2025: Patients in the UK will be able to access cutting-edge testing for Chronic Obstructive Pulmonary Disease (COPD) - the UK’s sixth biggest killer - as the NHS rolls out faster, ...
Medscape

MHRA Approves First Low-Carbon COPD Inhaler for UK Patients

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the world’s first low-carbon version of a triple-combination inhaler for chronic obstructive pulmonary disease (COPD). The ...
Healio

COPD detected early with AI-powered electrocardiogram interpretation

An AI-powered model that analyzes electrocardiograms was able to accurately detect COPD early in internal testing and ...